# EDGAR Filing Document

**Accession Number:** 0001113169
**File Stem:** 0001628280-26-028712
**Filing Date:** 2026-4
**Character Count:** 144872
**Document Hash:** c9209cd30211566e0a427b3047da536f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-028712.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001628280-26-028712

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 76

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRICE T ROWE GROUP INC
- **CENTRAL INDEX KEY:** 0001113169
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 522264646
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-32191
- **FILM NUMBER:** 26922304

**BUSINESS ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231
- **BUSINESS PHONE:** 4103452000

**MAIL ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231

?xml version='1.0' encoding='ASCII'? trow-20260331

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

______________________________________

**FORM 10-Q** 

______________________________________

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to** 

**Commission File Number: 000-32191** 

______________________________________

**T. ROWE PRICE GROUP, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Maryland** | **52-2264646** |
| **(State of incorporation)** | **(I.R.S. Employer Identification No.)** |

---

**1307 Point Street, Baltimore, Maryland 21231**

**(Address, including Zip Code, of principal executive offices)**

**(410) 345-2000** 

**(Registrant's telephone number, including area code)**

________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Common Stock, $0.20 par value per share** | **TROW** | **The NASDAQ Stock Market LLC** |

---

______________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Non-accelerated filer | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes&nbsp;&nbsp;&nbsp;&nbsp;☒ No

The number of shares outstanding of the issuer's common stock ($0.20 par value), as of the latest practicable date, April 28, 2026, is 214,266,606.

The exhibit index is at Item 6 on page 44.

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**UNAUDITED CONSOLIDATED BALANCE SHEETS**

**(in millions, except share data)** 

---

| | | |
|:---|:---|:---|
|  | **3/31/2026** | **12/31/2025** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $3729.8 | $3378.2 |
| &nbsp;&nbsp;Accounts receivable and accrued revenue | 909.9 | 931.2 |
| &nbsp;&nbsp;Investments | 3167.1 | 3325.2 |
| &nbsp;&nbsp;Assets of consolidated investment products ($1,550.8 million at March 31, 2026 and $1,596.1 million at December 31, 2025, related to variable interest entities) | 1954.5 | 1951.0 |
| &nbsp;&nbsp;Operating lease assets | 377.7 | 382.9 |
| &nbsp;&nbsp;Property, equipment and software, net | 818.5 | 845.3 |
| &nbsp;&nbsp;Intangible assets, net | 260.5 | 274.2 |
| &nbsp;&nbsp;Goodwill | 2642.8 | 2642.8 |
| &nbsp;&nbsp;Other assets | 532.2 | 611.0 |
| Total assets | $14393.0 | $14341.8 |
| **LIABILITIES** |  |  |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $369.5 | $352.7 |
| &nbsp;&nbsp;Liabilities of consolidated investment products ($98.0 million at March 31, 2026 and $14.2 million at December 31, 2025, related to variable interest entities) | 113.5 | 21.3 |
| &nbsp;&nbsp;Operating lease liabilities | 438.1 | 447.2 |
| &nbsp;&nbsp;Accrued compensation and related costs | 334.9 | 235.7 |
| &nbsp;&nbsp;Deferred compensation liabilities | 1129.2 | 1176.8 |
| &nbsp;&nbsp;Income taxes payable | 132.4 | 54.9 |
| Total liabilities | 2517.6 | 2288.6 |
| Commitments and contingent liabilities |  |  |
| Redeemable non-controlling interests | 940.2 | 1036.0 |
| **STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;Preferred stock, undesignated, $0.20 par value — authorized and unissued 20,000,000 shares |  |  |
| &nbsp;&nbsp;Common stock, $0.20 par value — authorized 750,000,000; issued 214,880,000 shares at March 31, 2026 and 218,565,000 at December 31, 2025 | 43.1 | 43.8 |
| &nbsp;&nbsp;&nbsp;Additional capital in excess of par value |  |  |
| &nbsp;&nbsp;&nbsp;Retained earnings | 10786.1 | 10866.8 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (51.6) | (50.5) |
| Total stockholders' equity attributable to T. Rowe Price Group | 10777.6 | 10860.1 |
| Non-controlling interests in consolidated entities | 157.6 | 157.1 |
| Total permanent stockholders' equity | 10935.2 | 11017.2 |
| Total liabilities, redeemable non-controlling interests, and permanent stockholders' equity | $14393.0 | $14341.8 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF INCOME**

**(in millions, except per-share amounts)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2025** |
| Revenues |  |  |
| &nbsp;&nbsp;&nbsp;Investment advisory fees | $1683.0 | $1598.4 |
| &nbsp;&nbsp;&nbsp;Performance-based advisory fees | 7.5 | 10.4 |
| &nbsp;&nbsp;&nbsp;Capital allocation-based income | 28.1 | (1.2) |
| &nbsp;&nbsp;&nbsp;Administrative, distribution, servicing, and other fees | 138.4 | 156.3 |
| &nbsp;&nbsp;&nbsp;Net revenues | 1857.0 | 1763.9 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 659.7 | 664.5 |
| &nbsp;&nbsp;&nbsp;Distribution and servicing costs | 99.3 | 93.6 |
| &nbsp;&nbsp;&nbsp;Advertising and promotion costs | 18.4 | 26.1 |
| &nbsp;&nbsp;&nbsp;Product and recordkeeping related costs | 74.3 | 83.8 |
| &nbsp;&nbsp;&nbsp;Technology, occupancy, and facility costs | 204.4 | 181.2 |
| &nbsp;&nbsp;&nbsp;General, administrative, and other costs | 92.4 | 89.7 |
| &nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairment costs | 18.0 | 28.7 |
| &nbsp;&nbsp;&nbsp;Restructuring charge | 10.0 |  |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 1176.5 | 1167.6 |
| Net operating income | 680.5 | 596.3 |
| Non-operating income (loss) |  |  |
| &nbsp;&nbsp;&nbsp;Net gains (losses) on investments | (6.1) | 31.9 |
| &nbsp;&nbsp;&nbsp;Net gains (losses) on consolidated investment products | (41.4) | 31.9 |
| &nbsp;&nbsp;&nbsp;Other gains (losses), including foreign currency gains (losses) | (0.8) | 6.9 |
| Total non-operating income (loss) | (48.3) | 70.7 |
| Income before income taxes | 632.2 | 667.0 |
| Provision for income taxes | 148.1 | 161.9 |
| Net income | 484.1 | 505.1 |
| &nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to redeemable non-controlling interests | (14.1) | 14.6 |
| Net income attributable to T. Rowe Price Group, Inc. | 498.2 | 490.5 |
| Earnings per share on common stock of T. Rowe Price Group, Inc. |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $2.23 | $2.15 |
| &nbsp;&nbsp;&nbsp;Diluted | $2.23 | $2.15 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(in millions)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2025** |
| Net income | $484.1 | $505.1 |
| Other comprehensive income (loss) |  |  |
| Currency translation adjustments |  |  |
| &nbsp;&nbsp;&nbsp;Consolidated investment products—variable interest entities | (1.4) | 7.7 |
| &nbsp;&nbsp;&nbsp;Reclassification (gains) losses recognized in non-operating income upon deconsolidation of certain investment products | (0.2) |  |
| &nbsp;&nbsp;&nbsp;Total currency translation adjustments of consolidated investment products—variable interest entities | (1.6) | 7.7 |
| &nbsp;&nbsp;&nbsp;Equity method investments | (0.6) | (4.3) |
| Other comprehensive income (loss) before income taxes | (2.2) | 3.4 |
| Net deferred tax (expense) benefit | 0.4 | (0.5) |
| Total other comprehensive income (loss) | (1.8) | 2.9 |
| Total comprehensive income | 482.3 | 508.0 |
| &nbsp;&nbsp;Less: comprehensive income (loss) attributable to redeemable non-controlling interests | (14.8) | 17.7 |
| Comprehensive income attributable to T. Rowe Price Group | $497.1 | $490.3 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in millions)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2025** |
| Cash flows from operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $484.1 | $505.1 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and impairment of property, equipment and software | 68.8 | 63.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization and impairment of acquisition-related assets and retention arrangements | 33.9 | 49.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 49.1 | 50.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses recognized on investments | 13.6 | (8.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net redemptions in investment products used to economically hedge deferred compensation liabilities | 39.2 | 45.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in securities held by consolidated investment products | (168.9) | (163.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other changes in assets and liabilities | 304.5 | 90.3 |
| &nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 824.3 | 632.9 |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of sponsored investment products | (10.3) | (73.6) |
| &nbsp;&nbsp;&nbsp;Dispositions of sponsored investment products | 82.6 | 119.8 |
| &nbsp;&nbsp;&nbsp;Net cash of investment products upon deconsolidation | (0.5) | 3.7 |
| &nbsp;&nbsp;&nbsp;Additions to property, equipment and software | (62.0) | (82.0) |
| &nbsp;&nbsp;&nbsp;Other investing activity | 49.8 | (15.7) |
| &nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | 59.6 | (47.8) |
| Cash flows from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;Repurchases of common stock | (333.5) | (215.2) |
| &nbsp;&nbsp;&nbsp;Common share issuances under stock-based compensation plans | 0.1 | 15.2 |
| &nbsp;&nbsp;&nbsp;Dividends paid to common stockholders and equity-unit holders | (289.1) | (289.5) |
| &nbsp;&nbsp;&nbsp;Net contributions (distributions) to non-controlling interests in consolidated entities | (10.9) | 0.1 |
| &nbsp;&nbsp;&nbsp;Net subscriptions from redeemable non-controlling interest holders | 131.4 | 78.0 |
| &nbsp;&nbsp;&nbsp;Net cash used in financing activities | (502.0) | (411.4) |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | (2.8) | 0.9 |
| Net change in cash and cash equivalents during period | 379.1 | 174.6 |
| Cash and cash equivalents at beginning of period, including $39.1 million at December 31, 2025, and $63.1 million at December 31, 2024, held by consolidated investment products | 3417.3 | 2712.9 |
| Cash and cash equivalents at end of period, including $66.6 million at March 31, 2026, and $50.8 million at March 31, 2025, held by consolidated investment products | $3796.4 | $2887.5 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY** 

**(shares in thousands; dollars in millions)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** |
| | **Common shares outstanding** | **Common stock** | **Additional capital in excess of par value** | **Retained earnings** | **AOCI**<sup>(1)</sup> | **Total stockholders' equity attributable to T. Rowe Price Group** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at December 31, 2025 | 218565 | $43.8 | $— | $10866.8 | $(50.5) | $10860.1 | $157.1 | $11017.2 | $1036.0 |
| Net income (loss) | **—** | **—** |  | 498.2 | **—** | 498.2 | 11.4 | 509.6 | (14.1) |
| Other comprehensive loss, net of tax | **—** | **—** |  |  | (1.1) | (1.1) |  | (1.1) | (0.7) |
| Dividends declared ($1.30 per share) | **—** | **—** |  | (288.4) |  | (288.4) |  | (288.4) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued upon option exercises | 4 |  | 0.3 |  |  | 0.3 |  | 0.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 5 |  | (0.2) |  |  | (0.2) |  | (0.2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | **—** | **—** | 49.1 |  |  | 49.1 |  | 49.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted stock units issued as dividend equivalents |  | **—** | 0.2 | (0.2) |  |  |  |  |  |
| Common shares repurchased | (3694) | (0.7) | (49.4) | (290.3) |  | (340.4) |  | (340.4) |  |
| Net distributions to non-controlling interests in consolidated entities | **—** | **—** |  |  |  |  | (10.9) | (10.9) |  |
| Net subscriptions into T. Rowe Price investment products | **—** | **—** | **—** | **—** |  |  |  |  | 117.1 |
| Net deconsolidations of T. Rowe Price investment products | **—** | **—** | **—** | **—** | **—** |  |  |  | (198.1) |
| Balances at March 31, 2026 | 214880 | $43.1 | $— | $10786.1 | $(51.6) | $10777.6 | $157.6 | $10935.2 | $940.2 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** |
| | **Common shares outstanding** | **Common stock** | **Additional capital in excess of par value** | **Retained earnings** | **AOCI**<sup>(1)</sup> | **Total stockholders' equity attributable to T. Rowe Price Group** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at December 31, 2024 | 222966 | $44.6 | $311.9 | $10040.6 | $(51.7) | $10345.4 | $160.7 | $10506.1 | $944.0 |
| Net income (loss) | **—** | **—** | **—** | 490.5 | **—** | 490.5 | (0.4) | 490.1 | 14.6 |
| Other comprehensive income (loss), net of tax | **—** | **—** | **—** | **—** | (0.2) | (0.2) | **—** | (0.2) | 3.1 |
| Dividends declared ($1.27 per share) | **—** | **—** | **—** | (288.8) | **—** | (288.8) | **—** | (288.8) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares issued upon option exercises | 231 |  | 15.2 | **—** | **—** | 15.2 | **—** | 15.2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 5 |  | (0.2) | **—** | **—** | (0.2) | **—** | (0.2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | **—** | **—** | 50.3 | **—** | **—** | 50.3 | **—** | 50.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted stock units issued as dividend equivalents | **—** | **—** | 0.1 | (0.1) | **—** |  | **—** |  |  |
| Common shares repurchased | (2141) | (0.4) | (217.1) |  | **—** | (217.5) | **—** | (217.5) |  |
| Net contributions from non-controlling interests in consolidated entities | **—** | **—** | **—** | **—** | **—** | **—** | 0.1 | 0.1 |  |
| Net subscriptions into T. Rowe Price investment products | **—** | **—** | **—** | **—** | **—** | **—** | **—** |  | 90.6 |
| Net deconsolidations of T. Rowe Price investment products | **—** | **—** | **—** | **—** | **—** | **—** | **—** |  | (75.1) |
| Balances at March 31, 2025 | 221061 | $44.2 | $160.2 | $10242.2 | $(51.9) | $10394.7 | $160.4 | $10555.1 | $977.2 |

---

<sup>(1)</sup> *Accumulated other comprehensive income*

The accompanying notes are an integral part of these statements.

------

**<u>NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**NOTE 1 – BASIS OF PREPARATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES.**

T. Rowe Price Group derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide globally to individual and institutional investors that invest in a broad range of investment solutions across equity, fixed income, multi-asset, and alternatives capabilities. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and other advisory services.

The investment solutions are provided in a number of vehicles including the T. Rowe Price U.S. mutual funds (U.S. mutual funds), subadvised funds, separately managed accounts, collective investment trusts, exchange-traded funds, and other sponsored products. The other sponsored products include: open-ended investment products offered to investors outside the U.S., products offered through variable annuity life insurance plans in the U.S., affiliated private investment funds, business development companies, an interval fund, and collateralized loan obligations.

Investment advisory fees depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.

***<u>BASIS OF PREPARATION.</u>***

These unaudited consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates.

Certain prior-period technology-related professional fees and servicing costs have been reclassified from general, administrative, and other costs to technology, occupancy, and facilities costs to conform with current year presentation. The new presentation better aligns the nature of the expenses following our decision to outsource and expand certain technology capabilities through trusted vendor partnerships. The amount reclassified for the first quarter of 2025 was $13.6 million. While the presentation of certain expense categories changed, the reclassifications did not impact previously reported total operating expenses, operating income, net income, or cash flows.

The unaudited financial information contained in these consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 2025 Annual Report.

***<u>NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.</u>***

In November 2024, the FASB issued Accounting Standards Update No. 2024-03 - *Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-4): Disaggregation of Income Statement Expenses*, which requires disclosures of additional information and disaggregation of certain expenses included in the income statement. The guidance is effective for the firm on January 1, 2027, and allows for either a prospective or retrospective approach on adoption. We are currently evaluating the impact the adoption will have on our financial statements and have not yet determined our transition approach.

In September 2025, the FASB issued Accounting Standards Update No. 2025-06 - *Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software*, which amends the existing internal-use software guidance. The amendment eliminates the project stage model and clarifies that capitalization of internal-use software costs commences when management has authorized and committed funding for the project and it is probable that software will be completed and used for its intended function. The amendment allows for varying transition approaches and is effective for the firm on January 1, 2028, with early adoption permitted. We are currently evaluating the impact the adoption will have on our financial statements and have not yet determined our transition approach.

**20**

------

We have considered all other newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited consolidated financial statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

**NOTE 2 – INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.**

Net revenues earned in the first quarter of 2026 and 2025 are included in the table below along with details of investment advisory revenues by underlying asset class. We also included average assets under management by asset class, on which we earn investment advisory fees.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in millions) | **3/31/2026** | **3/31/2025** |
| Investment advisory fees |  |  |
| &nbsp;&nbsp;Equity | $974.7 | $959.2 |
| &nbsp;&nbsp;Fixed income, including money market | 111.8 | 103.6 |
| &nbsp;&nbsp;Multi-asset | 509.1 | 454.7 |
| &nbsp;&nbsp;Alternatives | 87.4 | 80.9 |
| Total investment advisory fees | $1683.0 | $1598.4 |
| Performance-based advisory fees | 7.5 | 10.4 |
| Capital allocation-based income | 28.1 | (1.2) |
| Administrative, distribution, servicing, and other fees | 138.4 | 156.3 |
| Net revenues | $1857.0 | $1763.9 |
| Average AUM (in billions): |  |  |
| &nbsp;&nbsp;Equity | $861.2 | $826.3 |
| &nbsp;&nbsp;Fixed income, including money market | 213.7 | 191.6 |
| &nbsp;&nbsp;Multi-asset | 641.8 | 549.7 |
| &nbsp;&nbsp;Alternatives | 59.1 | 52.7 |
| Average AUM | $1775.8 | $1620.3 |

---

Total net revenues earned from sponsored investment products totaled $1,574.5 million and $1,471.3 million for the three months ended March 31, 2026 and 2025, respectively. Accounts receivable from these products aggregate to $678.7 million at March 31, 2026 and $664.2 million at December 31, 2025.

Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.6% at March 31, 2026 and 8.8% at December 31, 2025 of our assets under management.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**NOTE 3 – INVESTMENTS.**

The carrying values of our investments that are not consolidated investment products are as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **3/31/2026** | **12/31/2025** |
| Investments held at fair value |  |  |
| &nbsp;&nbsp;&nbsp;T. Rowe Price investment products |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discretionary investments | $459.5 | $463.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Redeemable seed capital investments | 317.3 | 316.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments used to hedge the deferred compensation liabilities | 1169.8 | 1243.3 |
| &nbsp;&nbsp;&nbsp;Investment partnerships and other investments | 70.6 | 154.7 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated collateralized loan obligations | 1.8 | 3.2 |
| Equity method investments |  |  |
| &nbsp;&nbsp;&nbsp;T. Rowe Price investment products - redeemable seed capital investments | 18.1 | 8.3 |
| &nbsp;&nbsp;&nbsp;Investment in UTI Asset Management Company Limited (India) | 165.7 | 162.8 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated private investment funds - carried interest | 377.4 | 390.3 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated private investment funds - seed/co-investment | 304.7 | 304.7 |
| &nbsp;&nbsp;&nbsp;Investment partnerships and other investments | 209.3 | 204.9 |
| Held to maturity |  |  |
| &nbsp;&nbsp;&nbsp;Investments in affiliated collateralized loan obligations | 21.5 | 21.8 |
| &nbsp;&nbsp;&nbsp;Certificates of deposit | 50.4 | 50.4 |
| &nbsp;&nbsp;U.S. Treasury note | 1.0 | 1.0 |
| Total | $3167.1 | $3325.2 |

---

During the three months ended March 31, 2026 and 2025, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we report our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. The net impact on our unaudited consolidated balance sheets and statements of income as of the dates the products were deconsolidated or reconsolidated is detailed below.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in millions) | **3/31/2026** | **3/31/2025** |
| Net decrease in assets of consolidated investment products | $(255.9) | $(422.7) |
| Net decrease in liabilities of consolidated investment products | $(1.4) | $(23.5) |
| Net decrease in redeemable non-controlling interests | $(198.1) | $(75.1) |
| Net gains recognized upon deconsolidation | $0.2 | $— |

---

The net gains recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain consolidated investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income.

**<u>INVESTMENTS AT FAIR VALUE</u>**

The investment partnerships and other investments held at fair value are valued using net asset value (NAV) per share as a practical expedient or using the measurement alternative. Our interests in the investment partnerships are generally not redeemable and are subject to significant transferability restrictions. The underlying investments of these partnerships have contractual terms through 2034, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three months ended March 31, 2026, we recognized $52.9 million of net unrealized losses on investments held at fair value that were still held at March 31, 2026. For the same period of 2025, we recognized $27.3 million of net unrealized losses on investments held at fair value that were still held at March 31, 2025.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>VARIABLE INTEREST ENTITIES.</u>**

Our fair value and equity method investments at March 31, 2026 and 2025 include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **3/31/2026** | **12/31/2025** |
| Investment carrying values | $989.7 | $978.7 |
| Unfunded capital commitments | 191.9 | 199.3 |
| Accounts receivable | 115.6 | 113.3 |
| Maximum risk of loss | $1297.2 | $1291.3 |

---

We have unfunded capital commitments, totaling $191.9 million at March 31, 2026 and $199.3 million at December 31, 2025, related primarily to the affiliated private investment funds and the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be recalled under certain circumstances.

Investments in affiliated private investment funds - carried interest represent interests in the general partners of affiliated private investment funds that are entitled to a disproportionate allocation of income, also known as carried interest. The entities that hold these interests (carried interest entities) are considered variable interest entities and are consolidated as T. Rowe Price is determined to be the primary beneficiary. The total assets, liabilities and non-controlling interests of these carried interest entities as of March 31, 2026 and December 31, 2025 are as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **3/31/2026** | **12/31/2025** |
| Assets | $420.6 | $438.7 |
| Liabilities | $0.7 | $5.8 |
| Non-controlling interest | $157.6 | $157.1 |

---

**<u>INVESTMENTS IN AFFILIATED COLLATERALIZED LOAN OBLIGATIONS.</u>**

There is debt associated with our investments in affiliated collateralized loan obligations. The debt outstanding is related to repurchase agreements of €18.6 million at March 31, 2026, compared to €18.6 million at December 31, 2025 (equivalent to $21.5 million at March 31, 2026 and $21.8 million at December 31, 2025 at the respective EUR spot rates) that are collateralized by the CLO investments and reported in accounts payable and accrued expenses in our consolidated balance sheets. These repurchase agreements bear interest at rates based on EURIBOR plus the initial margin, which equals all-in rates ranging from 3.0% to 10.9% as of March 31, 2026. The debt matures on various dates through 2035 or if the investments are paid back in full or cancelled, whichever is sooner.

**NOTE 4 – FAIR VALUE MEASUREMENTS.**

We determine the fair value of our cash equivalents and certain investments held at fair value using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical financial instruments accessible at the reporting date.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and credit spreads. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The inputs into the determination of fair value require significant management judgment or estimation. Investments in this category generally include investments for which there is not an actively-traded market. There are no level 3 investments at March 31, 2026 and December 31, 2025.

These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments and liabilities that are recognized in our unaudited consolidated balance sheets

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated investment products, which are presented separately in our unaudited consolidated balance sheets and are detailed in Note 5.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **3/31/2026** | **3/31/2026** | **12/31/2025** | **12/31/2025** |
| (in millions) | **Level 1** | **Level 2** | **Level 1** | **Level 2** |
| T. Rowe Price investment products |  |  |  |  |
| &nbsp;&nbsp;Cash equivalents held in money market funds | $3316.6 | $— | $3049.0 | $— |
| &nbsp;&nbsp;Discretionary investments | 459.5 |  | 463.7 |  |
| &nbsp;&nbsp;Redeemable seed capital investments | 261.3 | 56.0 | 258.6 | 57.5 |
| &nbsp;&nbsp;Investments used to hedge the deferred compensation liabilities | 1169.8 |  | 1243.3 |  |
| Other investments | 0.8 |  | 0.3 |  |
| Investments in affiliated collateralized loan obligations |  | 1.8 |  | 3.2 |
| Total | $5208.0 | $57.8 | $5014.9 | $60.7 |

---

The fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient or the measurement alternative. The carrying value of these investments as disclosed in Note 3 were $69.8 million at March 31, 2026 and $154.4 million at December 31, 2025.

**NOTE 5 – CONSOLIDATED INVESTMENT PRODUCTS.**

The investment products that we consolidate in our consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds and certain other products are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.

The following table details the net assets of the consolidated investment products:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **3/31/2026** | **3/31/2026** | **3/31/2026** | **12/31/2025** | **12/31/2025** | **12/31/2025** |
| (in millions) | **Voting interest entities** | **Variable interest entities** | **Total** | **Voting interest entities** | **Variable interest entities** | **Total** |
| Cash and cash equivalents<sup>(1)</sup> | $5.3 | $61.3 | $66.6 | $3.0 | $36.1 | $39.1 |
| Investments<sup>(2)</sup> | 382.6 | 1466.7 | 1849.3 | 344.3 | 1541.2 | 1885.5 |
| Other assets | 15.8 | 22.8 | 38.6 | 7.6 | 18.8 | 26.4 |
| Total assets | 403.7 | 1550.8 | 1954.5 | 354.9 | 1596.1 | 1951.0 |
| Liabilities | 15.5 | 98.0 | 113.5 | 7.1 | 14.2 | 21.3 |
| Net assets | $388.2 | $1452.8 | $1841.0 | $347.8 | $1581.9 | $1929.7 |
| Attributable to T. Rowe Price Group | $276.4 | $624.4 | $900.8 | $269.8 | $623.9 | $893.7 |
| Attributable to redeemable non-controlling interests | 111.8 | 828.4 | 940.2 | 78.0 | 958.0 | 1036.0 |
|  | $388.2 | $1452.8 | $1841.0 | $347.8 | $1581.9 | $1929.7 |

---

<sup>(1)</sup> *Cash and cash equivalents includes $3.5 million at March 31, 2026 and $2.5 million at December 31, 2025 of investments in* 

&nbsp;&nbsp;&nbsp;&nbsp;*T. Rowe Price money market mutual funds.*

<sup>(2)</sup> *Investments include $86.8 million at March 31, 2026 and $61.7 million at December 31, 2025 of other T. Rowe Price investment products.*

Although we can generally redeem our net interest in the consolidated investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.

Since third-party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated investment products is limited to valuation changes associated with our net interest.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

However, we are required to recognize the valuation changes associated with all underlying investments held by these products in our consolidated statements of income and disclose the portion attributable to unrelated third-party investors as net income attributable to redeemable non-controlling interests.

The operating results of the consolidated investment products for the three months ended March 31, 2026 and 2025 are reflected in our unaudited consolidated statements of income as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2026** | **3/31/2026** | **3/31/2025** | **3/31/2025** | **3/31/2025** |
| (in millions) | **Voting interest entities** | **Variable interest entities** | **Total** | **Voting interest entities** | **Variable interest entities** | **Total** |
| Operating expenses reflected in net operating income | $(0.2) | $(2.5) | $(2.7) | $(0.2) | $(2.3) | $(2.5) |
| Net investment income (loss) reflected in non-operating income (loss) | (3.0) | (38.4) | (41.4) | 15.1 | 16.8 | 31.9 |
| Impact on income before taxes | $(3.2) | $(40.9) | $(44.1) | $14.9 | $14.5 | $29.4 |
| Net income (loss) attributable to T. Rowe Price Group | $(2.8) | $(27.2) | $(30.0) | $10.2 | $4.6 | $14.8 |
| Net income (loss) attributable to redeemable non-controlling interests | (0.4) | (13.7) | (14.1) | 4.7 | 9.9 | 14.6 |
|  | $(3.2) | $(40.9) | $(44.1) | $14.9 | $14.5 | $29.4 |

---

The operating expenses of the consolidated investment products are reflected in general, administrative and other expenses. In preparing our unaudited consolidated financial statements, we eliminated operating expenses of $1.1 million and $1.4 million for the three months ended March 31, 2026 and 2025, respectively, against the investment advisory and administrative fees earned from these products. The net investment income (loss) reflected in non-operating income (loss) includes dividend and interest income as well as realized and unrealized gains and losses on the underlying securities held by the consolidated investment products.

The following table details the impact of these consolidated investment products on the individual lines of our unaudited consolidated statements of cash flows.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2026** | **3/31/2026** | **3/31/2025** | **3/31/2025** | **3/31/2025** |
| (in millions) | **Voting interest entities** | **Variable interest entities** | **Total** | **Voting interest entities** | **Variable interest entities** | **Total** |
| Net cash provided by (used in) operating activities | $(80.6) | $(58.5) | $(139.1) | $(79.6) | $(57.5) | $(137.1) |
| Net cash provided by (used in) investing activities |  | (0.5) | (0.5) | 0.7 | 3.0 | 3.7 |
| Net cash provided by (used in) financing activities | 82.9 | 87.0 | 169.9 | 72.1 | 48.1 | 120.2 |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products |  | (2.8) | (2.8) |  | 0.9 | 0.9 |
| Net change in cash and cash equivalents during period | 2.3 | 25.2 | 27.5 | (6.8) | (5.5) | (12.3) |
| Cash and cash equivalents at beginning of year | 3.0 | 36.1 | 39.1 | 7.2 | 55.9 | 63.1 |
| Cash and cash equivalents at end of period | $5.3 | $61.3 | $66.6 | $0.4 | $50.4 | $50.8 |

---

For the three months ended March 31, 2026, the net cash provided by (used in) financing activities includes $38.5 million of net subscriptions we made into the consolidated investment products, net of dividends received. For the three months ended March 31, 2025, the net cash provided by (used in) financing activities included $42.2 million of net subscriptions we made into the consolidated investment products, net of dividends received. These cash flows were eliminated in consolidation.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>FAIR VALUE MEASUREMENTS.</u>**

We determine the fair value of investments held by consolidated investment products using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical financial instruments accessible at the reporting date.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and credit spreads. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The inputs into the determination of fair value require significant management judgment or estimation. Investments in this category generally include investments for which there is not an actively-traded market. There are no level 3 investments at March 31, 2026 and December 31, 2025.

These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated investment products using fair value measurements determined based on the differing levels of inputs.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **3/31/2026** | **3/31/2026** | **12/31/2025** | **12/31/2025** |
| (in millions) | **Level 1** | **Level 2** | **Level 1** | **Level 2** |
| Assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash equivalents | $4.8 | $— | $2.8 | $— |
| &nbsp;&nbsp;&nbsp;Equity securities | 339.4 | 268.8 | 475.2 | 376.5 |
| &nbsp;&nbsp;&nbsp;Fixed income securities |  | 1144.2 |  | 1002.5 |
| &nbsp;&nbsp;&nbsp;Other investments | 1.4 | 66.4 | 0.4 | 30.9 |
|  | $345.6 | $1479.4 | $478.4 | $1409.9 |
| Liabilities | $(0.9) | $(18.5) | $(0.3) | $(5.1) |

---

The fair value hierarchy level table above does not include investments for which fair value is estimated using their measurement alternative. The carrying value of these investments were $29.1 million at March 31, 2026.

At March 31, 2026, we consolidated an affiliated private investment fund that has unfunded capital commitments of $187.9 million of which $44.1 million is attributable to T. Rowe Price Group.

**NOTE 6 – GOODWILL AND INTANGIBLE ASSETS.**

Goodwill and intangible assets consist of the following:

---

| | | |
|:---|:---|:---|
| (in millions) | **3/31/2026** | **12/31/2025** |
| Goodwill | $2642.8 | $2642.8 |
| Indefinite-lived intangible assets - trade name | 86.0 | 86.0 |
| Indefinite-lived intangible assets - investment advisory agreements | 62.3 | 62.3 |
| Definite-lived intangible assets - investment advisory agreements | 112.2 | 125.9 |
| Total | $2903.3 | $2917.0 |

---

Amortization and impairment expense for the definite-lived investment advisory agreements intangible assets was $13.7 million and $24.4 million for the three months ended March 31, 2026 and 2025, respectively. Estimated amortization expense for the definite-lived investment advisory agreements intangible assets for the five succeeding years is as follows:

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| (in millions) |  |
| &nbsp;&nbsp;Remaining 2026 | $40.9 |
| &nbsp;&nbsp;&nbsp;2027 | 39.1 |
| &nbsp;&nbsp;&nbsp;2028 | 11.8 |
| &nbsp;&nbsp;&nbsp;2029 | 8.8 |
| &nbsp;&nbsp;&nbsp;2030 and after | 11.6 |
|  | $112.2 |

---

We evaluate the carrying amount of goodwill in our unaudited consolidated balance sheets for possible impairment on an annual basis in the fourth quarter or if triggering events occur that require us to evaluate for impairment earlier. No triggering events arose during the three months ended March 31, 2026.

**NOTE 7 – LONG-TERM INCENTIVE COMPENSATION.**

**<u>RESTRICTED STOCK UNITS.</u>**

The following table summarizes the status of, and changes in, our nonvested restricted stock units during the three months ended March 31, 2026.

---

| | | |
|:---|:---|:---|
| | **Restricted<br>stock<br>units** | **Weighted-<br>average<br>fair value** |
| Nonvested at December 31, 2025 | 5918352 | $114.80 |
| Time-based grants | 10421 | $104.71 |
| Vested | (7293) | $122.95 |
| Forfeited | (70508) | $117.57 |
| Nonvested at March 31, 2026 | 5850972 | $114.74 |

---

Nonvested at March 31, 2026 includes performance-based restricted stock units of 384,080. These nonvested performance-based restricted stock units include 110,794 units for which the performance period has lapsed, and the performance threshold has been met.

**<u>FUTURE STOCK-BASED COMPENSATION EXPENSE.</u>**

The following table presents the compensation expense to be recognized over the requisite service period of the stock-based awards outstanding at March 31, 2026. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met and adjustments for actual forfeitures.

---

| | |
|:---|:---|
| (in millions) |  |
| Second quarter 2026 | $48.5 |
| Third quarter 2026 | 42.8 |
| Fourth quarter 2026 | 37.2 |
| 2027 | 80.3 |
| 2028 through 2031 | 61.4 |
| Total | $270.2 |

---

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>RESTRICTED FUND UNITS.</u>**

The following table summarizes changes in the restricted fund units liability, which is reported in deferred compensation liabilities on the unaudited consolidated balance sheet, for the three months ended March 31, 2025 and 2026.

---

| | | |
|:---|:---|:---|
| (in millions) | **2026** | **2025** |
| Balance at beginning of period | $54.7 | $14.7 |
| Amortization of grant date value | 18.3 | 11.8 |
| Amortization of market appreciation (depreciation) | (1.5) | (0.5) |
| Forfeitures | (0.6) |  |
| Balance at March 31 | $70.9 | $26.0 |

---

The following table presents the compensation expense to be recognized over the requisite service period of the restricted fund units outstanding at March 31, 2026. Estimated future compensation expense will change to reflect future grants, changes in the market value of the restricted fund units, which is based on selected hypothetical investments, and adjustments for actual forfeitures. The grants outstanding will vest by 2030.

---

| | |
|:---|:---|
| (in millions) |  |
| Second quarter 2026 | $17.5 |
| Third quarter 2026 | 17.0 |
| Fourth quarter 2026 | 13.8 |
| 2027 | 33.6 |
| 2028 through 2030 | 30.2 |
| Total | $112.1 |

---

**NOTE 8 – EARNINGS PER SHARE CALCULATIONS.**

The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in millions) | **3/31/2026** | **3/31/2025** |
| Net income attributable to T. Rowe Price Group | $498.2 | $490.5 |
| Less: net income allocated to outstanding restricted stock and stock unit holders | 12.5 | 12.4 |
| Net income allocated to common stockholders | $485.7 | $478.1 |
| Weighted-average common shares |  |  |
| &nbsp;&nbsp;&nbsp;Outstanding | 217.5 | 222.3 |
| &nbsp;&nbsp;&nbsp;Outstanding assuming dilution | 217.6 | 222.6 |

---

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**NOTE 9 – OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.**

The changes in each component of accumulated other comprehensive income (loss), including reclassification adjustments, are presented in the table below.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** |
| (in millions) | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** |
| Balances at beginning of period | $(57.4) | $6.9 | $(50.5) | $(49.5) | $(2.2) | $(51.7) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | (0.6) | (0.7) | (1.3) | (4.3) | 4.6 | 0.3 |
| &nbsp;&nbsp;&nbsp;Reclassification adjustments recognized in non-operating income |  | (0.2) | (0.2) |  |  |  |
| Other comprehensive income (loss) before income taxes | (0.6) | (0.9) | (1.5) | (4.3) | 4.6 | 0.3 |
| &nbsp;&nbsp;&nbsp;Net deferred tax benefits (income taxes) | 0.1 | 0.3 | 0.4 | 0.6 | (1.1) | (0.5) |
| Other comprehensive income (loss) | (0.5) | (0.6) | (1.1) | (3.7) | 3.5 | (0.2) |
| Balances at end of period | $(57.9) | $6.3 | $(51.6) | $(53.2) | $1.3 | $(51.9) |

---

The other comprehensive income (loss) in the table above excludes net losses of $0.7 million and net gains of $3.1 million for the three months ended March 31, 2026 and 2025, respectively, related to redeemable non-controlling interests held in our consolidated investment products.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**NOTE 10 – SEGMENT REPORTING.**

We have one reportable segment: investment management services. We derive our revenue and net income globally and manage business activities on a consolidated basis.

We largely derive our revenues and net income from investment advisory services provided to individual and institutional investors. We also provide certain administrative services, including mutual fund transfer agent, fund and product accounting, distribution, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; and other advisory services. Our revenues and net income depend largely on the total value and composition of our assets under management, as such, the consideration for our services is generally variable and recognized over time.

Our chief operating decision maker (CODM) is the chief executive officer. The CODM utilizes consolidated net income attributable to T. Rowe Price Group as reported on the consolidated statements of income and certain non-GAAP metrics to assess performance and allocate resources. Based on these metrics, the CODM decides either to reinvest profits into the business based on our strategic priorities and/or return cash to stockholders through dividends and share repurchases.

We determined there are no significant segment expenses that require a separate disclosure, as the major categories of expenses regularly reviewed by the CODM to manage operations are disclosed in the consolidated statements of income. Quarterly reviews of expenses highlight those influenced by financial markets, such as distribution and servicing costs, as well as those that are both qualitatively and quantitatively significant. The measure of segment assets is reported on the consolidated balance sheet as total assets.

**NOTE 11 – COMMITMENTS AND CONTINGENCIES.**

**<u>COMMITMENTS.</u>**

T. Rowe Price Group has committed $249 million for investment in future OHA product launches through 2026. In April, we agreed to extend the commitment to 2030.

**<u>CONTINGENCIES.</u>**

**<u>Contingent Consideration</u>**

As part of the purchase consideration for our acquisition of OHA in December 2021, there is contingent

consideration in the amount of up to $900 million, payable in cash, that may be due as part of an earnout payment in 2026 and 2027 upon satisfying or exceeding certain defined revenue targets. These defined revenue targets will be evaluated on a cumulative basis from 2022 through 2026. About 22% of the earnout is conditioned upon continued service with T. Rowe Price Group and was excluded from the purchase consideration and deemed compensatory. The fair value of the earnout is remeasured each reporting period and was valued at zero as of March 31, 2026 and December 31, 2025.

**<u>Other</u>**

Various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.

**NOTE 12 – RESTRUCTURING CHARGE.**

As separately disclosed in the unaudited consolidated statements of income, we recognized a restructuring charge of $10.0 million, primarily severance, in the first quarter of 2026, related to actions taken under a broad and ongoing expense management program, which is designed to reduce expense growth and realign resources to support investment in existing and future capabilities. At March 31, 2026, we had $5.2 million in accrued compensation and related costs related to this program.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors

T. Rowe Price Group, Inc.:

*Results of Review of Interim Financial Information* 

We have reviewed the consolidated balance sheet of T. Rowe Price Group, Inc. and subsidiaries (the Company) as of March 31, 2026, the related consolidated statements of income, comprehensive income, stockholders' equity, and cash flows for the three-month periods ended March 31, 2026 and 2025, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2025, and the related consolidated statements of income, comprehensive income, stockholders' equity, and cash flows for the year then ended (not presented herein); and in our report dated February 13, 2026, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2025, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

*Basis for Review Results*

This consolidated interim financial information is the responsibility of the Company's management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

Baltimore, Maryland

April 30, 2026

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

***<u>OVERVIEW.</u>***

Our revenues and net income are derived primarily from investment advisory services provided globally to individual and institutional investors in a broad range of investment solutions across equity, fixed income, multi-asset, and alternatives capabilities. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and other advisory services.

Investment advisory fees depend largely on the total value and composition of our assets under management. Accordingly, fluctuations in financial markets and in the composition of assets under management affect our revenues and results of operations.

We incur significant expenditures to develop new products and services and improve and expand our capabilities and distribution channels in order to attract new clients and additional investments from our existing clients. These efforts often involve costs that precede any future revenues we may recognize from an increase to our assets under management.

The investment management industry is evolving, facing challenging trends such as passive strategies taking market share from traditional active strategies; continued downward fee pressure; demand for new investment vehicles to meet client needs; and an ever-changing regulatory landscape. In this regard, we have ample liquidity and resources that allow us to take advantage of attractive growth opportunities. Furthermore, we have developed a broad and ongoing plan to align our expense growth with anticipated revenue growth. As a result, we have initiated certain actions to reduce expense growth, realign resources, and invest in existing and future capabilities, while also helping to offset ongoing inflationary pressures on compensation and contractual spending. These investments include hiring investment and distribution professionals, adopting new technologies, and offering new products to provide our clients with strong investment management expertise and services.

***<u>MARKET TRENDS.</u>***

Global financial markets experienced increased volatility during the first quarter of 2026. In the U.S., equity markets produced mixed results during the quarter. Equity prices advanced early in the quarter amid solid corporate earnings and generally favorable economic data. Later in the quarter, heightened geopolitical tensions disrupted global energy supply conditions, leading to a sharp increase in oil prices and a corresponding reassessment of inflation risks. This shift contributed to increased market volatility and downward pressure on equity valuations, particularly toward the end of the quarter.

Performance varied across market capitalizations and investment styles. Small- and mid-capitalization stocks outperformed large-cap stocks, and value-oriented equities outperformed growth equities across capitalization ranges. Energy stocks significantly outperformed amid higher commodity prices along with materials and utilities. In contrast, consumer discretionary, financials, information technology, and communication services underperformed.

Developed international and emerging equity markets were modestly negative for the quarter. Early gains were offset by late-quarter declines as higher energy costs weighed on growth expectations, particularly in regions dependent on imported energy.

Returns of several major equity market indexes were as follows:

---

| | |
|:---|:---|
|<br>**Index** | **Three months ended**<br>**3/31/2026** |
| S&P 500 Index | (4.3)% |
| NASDAQ Composite Index<sup>(1)</sup> | (7.1)% |
| Russell 2000 Index | 0.9% |
| MSCI EAFE (Europe, Australasia, and Far East) Index | (1.1)% |
| MSCI Emerging Markets Index | (0.1)% |

---

<sup>(1)</sup> *Returns exclude dividends*

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Global bond returns were modestly negative in the first quarter of 2026. In the U.S., fixed income markets were relatively flat during the quarter. Earlier gains were reversed later in the period as rising energy prices contributed to upward pressure on inflation expectations. Heightened geopolitical uncertainty increased interest rate volatility and complicated expectations regarding the duration of restrictive monetary policy. The Federal Reserve maintained its policy rate during the quarter, reflecting a continued data-dependent stance amid evolving economic and geopolitical conditions.

Mortgage-backed and asset-backed securities outperformed, while corporate bonds underperformed as credit spreads widened later in the quarter. Treasury securities posted modest losses. The U.S. dollar weakened early in the quarter amid shifting global capital flows before strengthening later as risk aversion increased.

International fixed income markets posted negative returns for the quarter, driven primarily by rising sovereign yields late in the period. Earlier gains supported by easing inflation trends were offset as geopolitical developments led to sharp increases in energy prices and a broad reassessment of inflation outlooks and anticipated central bank policy actions across major regions.

Emerging market bonds also declined during the quarter. Hard-currency sovereign bonds were negatively affected by widening credit spreads as investors reassessed sovereign credit risk amid tighter global financial conditions. Local-currency emerging market debt experienced additional pressure from rising domestic yields and currency depreciation later in the period, reflecting increased risk aversion and U.S. dollar strength. Earlier supportive conditions for emerging market fixed income were outweighed as geopolitical risks intensified toward quarter-end.

Returns of several major bond market indexes were as follows:

---

| | |
|:---|:---|
|<br>**Index** | **Three months ended**<br>**3/31/2026** |
| Bloomberg Barclays U.S. Aggregate Bond Index | (0.1)% |
| J.P. Morgan Global High Yield Index | (0.2)% |
| Bloomberg Barclays Municipal Bond Index | (0.2)% |
| Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index | (1.9)% |
| J.P. Morgan Emerging Markets Bond Index Plus | (0.5)% |
| Bank of America US High Yield Index | (0.6)% |
| Credit Suisse Leveraged Loan Index | (0.5)% |

---

***<u>ASSETS UNDER MANAGEMENT.</u>***<sup>(1)</sup>

Assets under management ended the first quarter of 2026 at $1,709.7 billion, a decrease of $65.9 billion from December 31, 2025. The decrease was driven by market depreciation of $52.2 billion and net cash outflows of $13.7 billion.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following table details changes in our assets under management, by asset class, during the first quarter of 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** |
| (in billions) | **Equity** | **Fixed income, including money market** | **Multi-asset**<sup>(2)</sup> | **Alternatives**<sup>(3)</sup> | **Total** |
| Assets under management at beginning of period | $878.5 | $211.6 | $627.0 | $58.5 | $1775.6 |
| Net cash flows prior to manager-driven distributions | (22.6) | 3.5 | 4.1 | 2.2 | (12.8) |
| Manager-driven distributions |  |  |  | (0.9) | (0.9) |
| Net cash flows | (22.6) | 3.5 | 4.1 | 1.3 | (13.7) |
| Net market appreciation (depreciation) and income<sup>(4)</sup> | (45.4) | (0.5) | (6.1) | (0.2) | (52.2) |
| Change during the period | (68.0) | 3.0 | (2.0) | 1.1 | (65.9) |
| Assets under management at March 31, 2026 | $810.5 | $214.6 | $625.0 | $59.6 | $1709.7 |

---

<sup>(1)</sup> *Includes fee earning assets in which T. Rowe Price and its affiliates have full discretionary authority along with managed account - model delivery assets.*

<sup>(2)</sup> *&nbsp;&nbsp;&nbsp;&nbsp;The underlying assets under management of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.*

<sup>(3)</sup> *The alternatives asset class includes strategies authorized to invest more than 50% of its holdings in private credit, leveraged loans, mezzanine, real assets/CRE, structured products, stressed / distressed, non-investment grade CLOs, special situations, private equity, or have absolute return as its investment objective. Generally, only those strategies with longer than daily liquidity are included. Unfunded capital commitments were $20.9 billion at March 31, 2026 and $21.6 billion at December 31, 2025 and are not reflected in fee basis AUM above.*

<sup>(4)</sup> *Includes net distributions not reinvested for the first quarter of 2026 of $0.6.*

Investment advisory clients outside the United States account for 8.6% of our assets under management at March 31, 2026 and 8.8% at December 31, 2025.

Assets under management in our target date retirement products, which are included in the multi-asset totals shown above, were $561.3 billion at March 31, 2026, compared with $561.4 billion at December 31, 2025. Net flows into these portfolios were $4.9 billion in the first quarter of 2026.

Our multi-asset investment division provides advisory solutions that include investment insights, strategic asset allocation design, tactical asset allocation recommendations, and portfolio rebalancing services. The assets in these solutions, predominantly in the United States, were $27.8 billion at March 31, 2026 and December 31, 2025.

We provide participant accounting and plan administration for defined contribution retirement plans that primarily invest in our U.S. mutual funds, collective investment trusts and funds managed outside of our complex. As of March 31, 2026, our assets under administration were $314 billion, of which $176 billion are assets we manage.

***<u>INVESTMENT PERFORMANCE.</u>***<sup>(1)</sup>

Strong investment performance and brand awareness is a key driver to attracting and retaining assets—and to our long-term success. Our performance disclosures include specific asset classes, assets under management weighted performance, U.S. fund performance against passive peers, and composite performance against benchmarks. The following tables present investment performance for the one-, three-, five-, and 10-years ended March 31, 2026. Past performance is not a guarantee nor a reliable indicator of future performance.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 35% | 50% | 44% | 58% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 59% | 55% | 55% | 57% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 27% | 62% | 30% | 62% |
| &nbsp;&nbsp;&nbsp;&nbsp;All funds | 39% | 56% | 43% | 59% |
| **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 19% | 37% | 40% | 39% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 47% | 58% | 48% | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 26% | 47% | 21% | 52% |
| &nbsp;&nbsp;&nbsp;&nbsp;All funds | 28% | 46% | 36% | 47% |
| **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 17% | 25% | 24% | 45% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 55% | 61% | 55% | 69% |
| &nbsp;&nbsp;&nbsp;&nbsp;All composites | 34% | 40% | 36% | 54% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>AUM Weighted Performance</u>** | | | | |
| **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 21% | 63% | 41% | 73% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 84% | 77% | 81% | 77% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 11% | 90% | 52% | 93% |
| &nbsp;&nbsp;&nbsp;&nbsp;All funds | 23% | 71% | 46% | 78% |
| **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 6% | 40% | 25% | 42% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 72% | 77% | 80% | 58% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 11% | 67% | 16% | 94% |
| &nbsp;&nbsp;&nbsp;&nbsp;All funds | 10% | 49% | 26% | 56% |
| **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 13% | 33% | 18% | 39% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income | 63% | 60% | 55% | 67% |
| &nbsp;&nbsp;&nbsp;&nbsp;All composites | 23% | 38% | 26% | 44% |

---

As of March 31, 2026, 68 of 140 (48.6%) of the firm's rated U.S. mutual funds (across primary share classes) received an overall rating of 4 or 5 stars. By comparison, 32.5% of Morningstar's fund population is given a rating of 4 or 5 stars<sup>(6)</sup>. In addition, 61.0%<sup>(6)</sup> of AUM in the firm's rated U.S. mutual funds (across primary share classes) ended March 31, 2026 with an overall rating of 4 or 5 stars.

<sup>(1)</sup> *The investment performance reflects that of T. Rowe Price U.S. mutual funds, ETFs, and composites.* 

<sup>(2)</sup> *Source:© 2026 Morningstar, Inc. All rights reserved. The information contained herein: 1) is proprietary to Morningstar and/or its content providers; 2) may not be copied or distributed; and 3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.* 

<sup>(3)</sup> *Source: Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that outperformed the Morningstar category median. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $306B for 1 year, $294B for 3 years, $293B for 5 years, and $292B for 10 years.* 

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*analysis compares T. Rowe Price active funds with the applicable universe of passive/index open-end funds and ETFs of peer firms. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that outperformed the passive peer universe. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $293B for 1 year, $244B for 3 years, $239B for 5 years, and $231B for 10 years.*

<sup>(5)</sup> *Composite net returns are calculated using the highest applicable separate account fee schedule. Excludes money market composites. All composites compared to official GIPS composite primary benchmark. The top chart reflects the percentage of T. Rowe Price composites with 1 year, 3 year, 5 year, and 10 year track record that are outperforming their benchmarks. The bottom chart reflects the percentage of T. Rowe Price composite AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $1,501B for 1 year, $1,494B for 3 years, $1,487B for 5 years, and $1,453B for 10 years.* 

<sup>(6)</sup> *The Morningstar Rating™ for funds is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. Morningstar gives its best ratings of 5 or 4 stars to the top 32.5% of all funds (of the 32.5%,10% get 5 stars and 22.5% get 4 stars). The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund's 3, 5, and 10 year (if applicable) Morningstar Rating™ metrics.*

***<u>RESULTS OF OPERATIONS.</u>***

The following table and discussion sets forth information regarding our consolidated financial results for the first quarter of 2026 and 2025 on a U.S. GAAP and a non-GAAP basis. The non-GAAP basis adjusts for the impact of our consolidated investment products, the impact of market movements on the deferred compensation liabilities and related economic hedges, investment income related to certain other investments, acquisition-related amortization and costs, impairment charges, and certain nonrecurring charges and gains, including the restructuring charges.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q1 2026 vs. Q1 2025** | **Q1 2026 vs. Q1 2025** |
| (in millions, except per-share data) | **3/31/2026** | **3/31/2025** | **$ Change** | **% Change**<sup>(1)</sup> |
| **<u>U.S. GAAP basis</u>** |  |  |  |  |
| Investment advisory fees | $1683 | $1598.4 | $84.6 | 5.3% |
| Capital allocation-based income<sup>(2)</sup> | $28.1 | $(1.2) | $29.3 | n/m |
| Net revenues | $1857 | $1763.9 | $93.1 | 5.3% |
| Operating expenses | $1176.5 | $1167.6 | $8.9 | 0.8% |
| Net operating income | $680.5 | $596.3 | $84.2 | 14.1% |
| Non-operating income (loss) | $(48.3) | $70.7 | $(119.0) | n/m |
| Net income to T. Rowe Price Group | $498.2 | $490.5 | $7.7 | 1.6% |
| Diluted earnings per common share | $2.23 | $2.15 | $0.08 | 3.7% |
| Weighted average common shares outstanding assuming dilution | 217.6 | 222.6 | (5.0) | (2.2)% |
| **<u>Adjusted basis</u>**<sup>(3)</sup> |  |  |  |  |
| Operating expenses | $1155.2 | $1135.1 | $20.1 | 1.8% |
| Operating expenses, excluding accrued carried interest related compensation | $1142.3 | $1131.2 | $11.1 | 1.0% |
| Net operating income | $706.1 | $640.6 | $65.5 | 10.2% |
| Non-operating income (loss) | $30.9 | $35.5 | $(4.6) | (13.0)% |
| Net income to T. Rowe Price Group | $562 | $509.3 | $52.7 | 10.3% |
| Diluted earnings per common share | $2.52 | $2.23 | $0.29 | 13.0% |
| **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** |
| Average AUM | $1775.8 | $1620.3 | $155.5 | 9.6% |
| Ending AUM | $1709.7 | $1566.3 | $143.4 | 9.2% |
| **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** |
| EFR without performance-based fees | 38.4 | 40.0 | (1.6) | (4.0)% |
| EFR with performance-based fees | 38.6 | 40.3 | (1.7) | (4.2)% |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.*

<sup>(2)</sup> *Capital allocation-based income represents the change in accrued carried interest.* 

<sup>(3)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.* 

**<u>Results Overview - Quarter ended March 31, 2026</u>**

*<u>Net revenues</u>* consist of investment advisory revenues; performance-based advisory fees; administrative, distribution, servicing, and other fees; and capital allocation-based income. More than 90% of our net revenues are related to investment advisory fees. Total net revenues were $1,857.0 million in the first quarter of 2026, a 5.3% increase over $1,763.9 million in the first quarter of 2025. The increase was primarily driven by a 5.3% increase in investment advisory fee revenue as higher overall markets increased average assets under management by 9.6% and a $29.3 million increase in capital allocation-based income (change in accrued carried interest) earned from investments in certain affiliated funds.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment advisory fees are generally earned based on the value and composition of our assets under management, which change based on fluctuations in financial markets and net cash flows. As our average assets under management increase or decrease in a given period, the level of our investment advisory fee revenue for that same period generally fluctuates in a similar manner. Our annualized effective fee rates can be impacted by market or cash flow related shifts among asset classes and products, including those with tiered-fee structures, along with price changes we make in existing products.

Capital allocation-based income will fluctuate quarter-to-quarter to reflect the adjustment to accrued carried interest for the change in value of certain affiliated funds assuming the funds' underlying investments were realized as of the end of the period.

*<u>Operating expenses</u>* on a U.S. GAAP basis were $1,176.5 million in the first quarter of 2026, a 0.8% increase over the comparable 2025 period. On a non-GAAP basis, adjusted operating expenses were $1,155.2 million, a 1.8% increase over the comparable 2025 period.

Compared to the first quarter of 2025, the increase in U.S. GAAP and adjusted operating expenses was driven by higher technology, occupancy, and facilities costs. Also, U.S. GAAP expenses were impacted by lower mark-to-market related to our deferred compensation liabilities and lower acquisition-related amortization costs, partially offset by the restructuring charge. These costs are not included in our non-GAAP operating expenses. See the GAAP to non-GAAP reconciliation at the end of the Results of Operations section of this Management's Discussion and Analysis.

*<u>Operating margin</u>* in the first quarter of 2026 was 36.6% on a U.S. GAAP basis, compared to 33.8% earned in the first quarter of 2025. The increase in our operating margin for the first quarter of 2026 compared to the 2025 period was driven by net revenue growth outpacing operating expense growth primarily due to higher investment advisory fees.

*<u>Diluted earnings per share</u>* was $2.23 for the first quarter of 2026 compared to $2.15 for the first quarter of 2025. The increase was primarily driven by a lower tax rate and lower weighted average shares outstanding compared to the 2025 period.

On a non-GAAP basis, diluted earnings per share was $2.52 for the first quarter of 2026 compared to $2.23 for the first quarter of 2025. The increase was primarily due to higher adjusted operating income and lower weighted average shares outstanding compared to the 2025 period.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>Net revenues</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q1 2026 vs. Q1 2025** | **Q1 2026 vs. Q1 2025** |
| (in millions) | **3/31/2026** | **3/31/2025** | **$ Change** | **% Change**<sup>(1)</sup> |
| **Investment advisory fees** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity | $974.7 | $959.2 | $15.5 | 1.6% |
| &nbsp;&nbsp;&nbsp;Fixed income, including money market | 111.8 | 103.6 | 8.2 | 7.9% |
| &nbsp;&nbsp;&nbsp;Multi-asset | 509.1 | 454.7 | 54.4 | 12.0% |
| &nbsp;&nbsp;&nbsp;Alternatives | 87.4 | 80.9 | 6.5 | 8.0% |
|  | 1683.0 | 1598.4 | 84.6 | 5.3% |
| **Performance-based advisory fees** | 7.5 | 10.4 | (2.9) | (27.9)% |
| **Capital allocation-based income** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in accrued carried interest | 31.3 | 9.2 | 22.1 | n/m |
| &nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairments | (3.2) | (10.4) | 7.2 | n/m |
|  | 28.1 | (1.2) | 29.3 | n/m |
| **Administrative, distribution, servicing, and other fees** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Administrative and other fees | 116.6 | 134.7 | (18.1) | (13.4)% |
| &nbsp;&nbsp;&nbsp;Distribution and servicing fees | 21.8 | 21.6 | 0.2 | 0.9% |
|  | 138.4 | 156.3 | (17.9) | (11.5)% |
| **Net revenues** | $1857.0 | $1763.9 | $93.1 | 5.3% |
| **Average AUM (in billions):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity | $861.2 | $826.3 | $34.9 | 4.2% |
| &nbsp;&nbsp;&nbsp;Fixed income, including money market | 213.7 | 191.6 | 22.1 | 11.5% |
| &nbsp;&nbsp;&nbsp;Multi-asset | 641.8 | 549.7 | 92.1 | 16.8% |
| &nbsp;&nbsp;&nbsp;Alternatives | 59.1 | 52.7 | 6.4 | 12.1% |
| **Average AUM** | $1775.8 | $1620.3 | $155.5 | 9.6% |
| **Ending AUM (in billions)** | $1709.7 | $1566.3 | $143.4 | 9.2% |
| **Investment advisory annualized effective fee rate (EFR) (in bps)** |  |  |  |  |
| EFR without performance-based fees | 38.4 | 40.0 | (1.6) | (4.0)% |
| EFR with performance-based fees | 38.6 | 40.3 | (1.7) | (4.2)% |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.*

*<u>Investment advisory fees</u>* in the first quarter of 2026 increased 5.3% over the comparable 2025 quarter as average assets under management increased $155.5 billion, or 9.6%, to $1,775.8 billion.

The average annualized effective fee rate earned for the first quarter of 2026 declined from the comparable 2025 period due to client flows and transfers creating a mix shift in assets under management toward lower fee products and asset classes.

*<u>Performance-based advisory fees</u>* in the first quarter of 2026 were primarily earned from alternative strategies, whereas in the 2025 comparative period fees were earned across equity and alternative strategies.

*<u>Capital allocation-based income</u>* includes the change in accrued carried interest along with acquisition-related amortization and impairments. For the 2026 quarter, accrued carried interest increased net revenues by $31.3 million, compared to $9.2 million in 2025, reflecting relative investment performance. The decrease in acquisition-related amortization and impairments from the comparable 2025 period primarily reflects amortization and impairments recognized over time, which reduced the remaining carrying value of the acquired-assets. We realized carried interest of $41.0 million in the first quarter of 2026 compared to $43.1 million in the 2025 period.

A portion of the capital allocation-based income is passed through to certain associates as compensation and the related expense is recognized in compensation and related costs with the unpaid amount reported as non-controlling interest on the unaudited consolidated balance sheet.

*<u>Administrative, distribution, servicing, and other fees</u>* in the first quarter of 2026 were $138.4 million, a decrease of $17.9 million, or 11.5%, from the comparable 2025 quarter. The decrease primarily reflects the reporting change implemented in Q3 2025, in which revenue earned from managed account - model delivery assets and certain other

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

advisory services began being reported within investment advisory fees, as well as the timing of cost reimbursements from the U.S. mutual funds.

Our net revenues reflect the elimination of advisory and administrative fee revenue earned from our consolidated

investment products. The corresponding expenses recognized by these products, and consolidated in our financial statements, were also eliminated from operating expenses. For the first quarter, we eliminated net revenue of $1.1 million in 2026 and $1.4 million in 2025.

**<u>Operating expenses</u>** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q1 2026 vs. Q1 2025** | **Q1 2026 vs. Q1 2025** |
| (in millions) | **3/31/2026** | **3/31/2025** | **$ Change** | **% Change**<sup>(1)</sup> |
| Compensation, benefits, and related costs | $655.1 | $657.9 | $(2.8) | (0.4)% |
| Acquisition-related retention agreements | 14.2 | 14.2 |  | —% |
| Capital allocation-based income compensation<sup>(2)</sup> | 11.4 | (0.4) | 11.8 | n/m |
| Market-related change in deferred compensation liabilities | (21.0) | (7.2) | (13.8) | n/m |
| Total compensation and related costs | 659.7 | 664.5 | (4.8) | (0.7)% |
| Distribution and servicing costs | 99.3 | 93.6 | 5.7 | 6.1% |
| Advertising and promotion costs | 18.4 | 26.1 | (7.7) | (29.5)% |
| Product and recordkeeping related costs | 74.3 | 83.8 | (9.5) | (11.3)% |
| Technology, occupancy, and facility costs<sup>(3)</sup> | 204.4 | 181.2 | 23.2 | 12.8% |
| General, administrative, and other costs<sup>(3)</sup> | 92.4 | 89.7 | 2.7 | 3.0% |
| Acquisition-related amortization and impairment costs | 18.0 | 28.7 | (10.7) | (37.3)% |
| Restructuring charge | 10.0 |  | 10.0 | n/m |
| &nbsp;&nbsp;Total operating expenses | $1176.5 | $1167.6 | $8.9 | 0.8% |
| Total adjusted operating expenses<sup>(4)</sup> | $1155.2 | $1135.1 | $20.1 | 1.8% |

---

<sup>(1)</sup> *n/m - The percentage change is not meaningful.*

<sup>(2)</sup> *Capital allocation-based income compensation represents the change in accrued carried interest compensation along with acquisition-related, non-cash amortization and impairments.*

<sup>(3)</sup> *In Q1 2026, we began reporting technology-related professional fees and servicing costs from general, administrative, and other costs to technology, occupancy, and facilities costs to better align with the nature of the expenses following the outsourcing and expansion of our technology capabilities through trusted vendor partnerships. Prior periods were recast to reflect this change. The amount reclassified for the first quarter of 2025 was $13.6M.*

<sup>(4)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.* 

*<u>Compensation, benefits, and related costs</u>* were $655.1 million for the first quarter of 2026, a decrease of $2.8 million, or 0.4%, compared to the 2025 quarter. The decrease was primarily due to lower salaries and related benefits, partially offset by higher long-term incentive compensation.

The firm employed 7,507 associates at March 31, 2026, a decrease of 3.4% from the end of 2025 and a decrease of 7.1% from March 31, 2025. The average associate headcount for the first quarter of 2026 was 7,617, a decrease of 6.0% compared to the 2025 period.

*<u>Distribution and servicing costs</u>* were $99.3 million for the first quarter of 2026, an increase of $5.7 million, or 6.1%, from $93.6 million recognized in the 2025 quarter. The increase was primarily driven by higher average assets under management distributed through intermediaries.

The costs in this expense category include amounts paid to third-party intermediaries that source the assets of certain share classes of our U.S. mutual funds, ETFs, and our international products, such as our Japanese ITMs and SICAVs. These costs are offset entirely by the investment advisory revenue we earn from these products, or in the case of the Advisor and R share classes of the U.S. mutual funds, are recognized in administrative, distribution, servicing, and other fees.

*<u>Advertising and promotion costs</u>* were $18.4 million in the first quarter of 2026, a decrease of $7.7 million, or 29.5%, compared to the $26.1 million recognized in the 2025 quarter. The decrease was primarily due to timing of media spend and events.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*<u>Product and recordkeeping related costs</u>* were $74.3 million in the first quarter of 2026, a decrease of $9.5 million, or 11.3%, compared to the 2025 quarter. The decrease was primarily due to the timing of costs reimbursed by our U.S. mutual funds. The offsetting reimbursement is recognized in administrative, distribution, servicing, and other fees revenue.

*<u>Technology, occupancy, and facility costs</u>* were $204.4 million in the first quarter of 2026, an increase of $23.2 million, or 12.8%, compared to the $181.2 million recognized in the 2025 quarter. The increase from the 2025 quarter was primarily due to higher technology costs, including cloud services, depreciation, and our decision in the prior year to outsource certain technology capabilities.

*<u>General, administrative, and other expenses</u>* were $92.4 million in the first quarter of 2026, an increase of $2.7 million, or 3.0%, compared to the $89.7 million recognized in the 2025 quarter. The increase was primarily due to higher external research and other general and administrative costs.

*<u>Acquisition-related amortization and impairment costs.</u>* As part of the purchase accounting for our acquisitions, we identified and separately recognized, at fair value, certain intangible assets. During the first quarter of 2026, we recognized $18.0 million in amortization and impairments compared to $28.7 million in the 2025 period. The decrease primarily reflects amortization and impairments recognized over time, which reduced the remaining carrying value of the related definite-lived intangibles.

*<u>Restructuring charge</u>* of $10.0 million in the first quarter of 2026 relates to actions taken under our previously announced broad and ongoing expense management program, which is designed to reduce expense growth and realign resources to support investment in existing and future capabilities. The charge reflects compensation-related costs, primarily severance.

**<u>Non-operating income (loss)</u>** 

The following table details the components of non-operating income (loss) for both the first quarter of 2026 and 2025.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in millions) | **3/31/2026** | **3/31/2025** |
| Net gains (losses) from non-consolidated investment products |  |  |
| Cash and discretionary investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | $34.2 | $30.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | (3.3) | 4.2 |
| **Total cash and discretionary investments** | **30.9** | **34.6** |
| Seed capital investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | 1.0 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | (11.2) | (11.3) |
| **Total seed capital investments** | **(10.2)** | **(11.1)** |
| **Total cash, discretionary, and seed investments** | **20.7** | **23.5** |
| Net gains (losses) recognized upon deconsolidation | 0.2 |  |
| Investments used to hedge the deferred compensation liabilities | (32.6) | (10.7) |
| **Total net gains (losses) from non-consolidated investment products** | **(11.7)** | **12.8** |
| Other investment income | 5.6 | 19.1 |
| **Net gains (losses) on investments** | **(6.1)** | **31.9** |
| Net gains (losses) on consolidated investment products | (41.4) | 31.9 |
| Other gains (losses), including foreign currency gains (losses) | (0.8) | 6.9 |
| **Non-operating income (loss)** | $**(48.3)** | $**70.7** |
| **Adjusted non-operating income (loss)**<sup>(1)</sup> | $**30.9** | $**35.5** |

---

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.* 

On an adjusted basis, non-operating income (loss) consists of investment gains/losses generated from our cash and discretionary investment portfolio. Lower investment gains earned by our investment portfolio during the first quarter of 2026 compared to the 2025 period was primarily due to overall lower market returns, partially offset by higher dividend income from higher cash and investment balances.

The table above includes the net investment income of the underlying portfolios included in the consolidated

sponsored investment products and not just the net investment income related to our ownership interest in the products. The table below shows the impact that the consolidated investment products had on the individual lines of our unaudited consolidated statements of income and the portion attributable to our interest:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in millions) | **3/31/2026** | **3/31/2025** |
| Operating expenses reflected in net operating income | $(2.7) | $(2.5) |
| Net investment income (loss) reflected in non-operating income | (41.4) | 31.9 |
| Impact on income before taxes | $(44.1) | $29.4 |
| Net income (loss) attributable to our interest in the consolidated investment products | $(30.0) | $14.8 |
| Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors) | (14.1) | 14.6 |
| Impact on income before taxes | $(44.1) | $29.4 |

---

**<u>Provision for income taxes</u>**

The following table reconciles the statutory federal income tax rate to our effective tax rate on a U.S. GAAP basis for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2025** |
| Statutory U.S. federal income tax rate | 21.0% | 21.0% |
| State income taxes, net of federal income tax benefits | 2.2 | 2.7 |
| Net (income) losses attributable to redeemable non-controlling interests<sup>(1)</sup> | (0.2) | (0.4) |
| Net excess tax benefits from stock-based compensation plans activity | (0.2) | (0.3) |
| Valuation allowances | (0.2) | 0.4 |
| Other items | 0.8 | 0.9 |
| Effective income tax rate | 23.4% | 24.3% |
| Adjusted effective tax rate | 23.7% | 24.7% |

---

<sup>(1)</sup> *Net income attributable to redeemable non-controlling interests represents the portion of earnings held in our consolidated investment products that are not taxable to the us despite being included in pre-tax income.*

The adjusted effective tax rate primarily adjusts for the impact of the consolidated investment products, including the net income attributable to redeemable non-controlling interests. Our adjusted effective tax rate was 23.7% in the first quarter of 2026 compared with 24.7% in 2025. The decrease in both the U.S. GAAP and adjusted effective tax rate is primarily due to lower state taxes resulting from prior period settlements and the reversal of certain deferred tax asset valuation allowances. The impact of these decreases on the U.S. GAAP effective tax rate were partially offset by a lower impact related to the net income attributable to redeemable noncontrolling interests.

We currently estimate that our effective tax rate for the full year 2026, on a U.S. GAAP and adjusted basis, will be in the range of 23.0% to 26.0%.

Our effective tax rate will continue to experience volatility in future periods due to, among other things, the impact market fluctuations in our stock price have on stock-based compensation tax benefits, changes in the mix of our earnings among countries with differing tax laws or rates, and changes in the valuation allowances of foreign-based deferred tax assets.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

***<u>NON-GAAP INFORMATION AND RECONCILIATION.</u>***

We believe the non-GAAP financial measures below provide relevant and meaningful information to investors about our core operating results. These measures have been established in order to increase transparency for the purpose of evaluating our core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.

The following schedules reconcile certain U.S. GAAP financial measures to non-GAAP financial measures for the three months ended March 31, 2026 and 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** | **Three months ended 3/31/2026** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1176.5 | $680.5 | $(48.3) | $148.1 | $498.2 | $2.23 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 1.5 | 1.7 |  | 0.5 | 1.2 | 0.01 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 4.2 | 10.0 | 0.04 |
| Intangible assets amortization and impairments<sup>(1)</sup> | (18.0) | 18.0 |  | 5.3 | 12.7 | 0.06 |
| Total acquisition-related | (30.7) | 33.9 |  | 10.0 | 23.9 | 0.11 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | 21.0 | (21.0) | 32.6 | 3.5 | 8.1 | 0.04 |
| Restructuring charge<sup>(3)</sup> | (10.0) | 10.0 |  | 3.0 | 7.0 | 0.03 |
| Consolidated investment products<sup>(4)</sup> | (1.6) | 2.7 | 41.4 | 8.9 | 21.1 | 0.09 |
| Other non-operating income<sup>(5)</sup> |  |  | 5.2 | 1.5 | 3.7 | 0.02 |
| **Adjusted Basis** | $1155.2 | $706.1 | $30.9 | $175.0 | $562.0 | $2.52 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** | **Three months ended 3/31/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1167.6 | $596.3 | $70.7 | $161.9 | $490.5 | $2.15 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 4.3 | 6.1 |  | 1.2 | 4.9 | 0.02 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 3.0 | 11.2 | 0.05 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (28.7) | 28.7 |  | 5.9 | 22.8 | 0.10 |
| Total acquisition-related | (38.6) | 49.0 |  | 10.1 | 38.9 | 0.17 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | 7.2 | (7.2) | 10.7 | 0.7 | 2.8 | 0.01 |
| Consolidated investment products<sup>(4)</sup> | (1.1) | 2.5 | (31.9) | (3.1) | (11.7) | (0.05) |
| Other non-operating income<sup>(5)</sup> |  |  | (14.0) | (2.8) | (11.2) | (0.05) |
| **Adjusted Basis** | $1135.1 | $640.6 | $35.5 | $166.8 | $509.3 | $2.23 |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;These non-GAAP adjustments remove the impact of acquisition-related amortization of intangible assets, the recurring fair value remeasurements of the contingent consideration liability, if any, amortization of acquired investment and non-controlling interest basis

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

differences and amortization of compensation-related arrangements. We believe adjusting for these charges helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment eliminates the compensation expense impact from market valuation changes in deferred compensation liabilities, including the supplemental savings plan and restricted fund units, and the related net gains (losses) on investments used as economic hedges against the related liabilities. The liabilities are adjusted based on the performance of hypothetical investments selected by participants. We use investment products to economically hedge the market risk associated with the supplemental savings plan liability and the expected settlement value of unvested restricted fund units. We believe it is useful to offset the non-operating investment income (loss) of the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the our core operating results and to increase comparability period to period.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes the impact of actions taken as part of our broad and ongoing plan to reduce expense growth and realign resources to invest in existing and future capabilities. We believe this adjustment helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(4)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes the impact of the consolidated investment products by adding back their operating expenses and subtracting their investment income. The operating expense adjustment represents their operating expenses net of related investment advisory and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the consolidated investment products' net income, net of redeemable non-controlling interests. We believe this adjustment helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(5)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes non-operating income (loss) earned on those investments that are not economic hedges for the deferred compensation liabilities and are not part of the cash and discretionary investment portfolio. We retain gains from cash and discretionary investments in our non-GAAP measures, as they are considered part of our core operations. We believe adjusting for the remaining non-operating income (loss) helps the reader's ability to understand our core operating results and increases comparability period to period. Additionally, we do not emphasize this portion of non-operating income (loss) when assessing our performance.

<sup>(6)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate. As such, the non-GAAP effective tax rate for the three months ended March 31, 2026 and 2025 was 23.7% and 24.7%, respectively.

<sup>(7)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to

&nbsp;&nbsp;&nbsp;&nbsp;T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2025** |
| Adjusted net income attributable to T. Rowe Price Group, Inc. | $562.0 | $509.3 |
| Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 14.1 | 12.9 |
| Adjusted net income allocated to common stockholders | $547.9 | $496.4 |

---

***<u>CAPITAL RESOURCES AND LIQUIDITY.</u>***

**<u>Sources of Liquidity</u>**

We have ample liquidity, including cash and investments in T. Rowe Price products, as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **3/31/2026** | **12/31/2025** |
| Cash and cash equivalents | $3729.8 | $3378.2 |
| Discretionary investments | 459.5 | 463.7 |
| Total cash and discretionary investments | 4189.3 | 3841.9 |
| Redeemable seed capital investments | 1133.9 | 1144.1 |
| Investments used to hedge the deferred compensation liabilities | 1243.0 | 1317.3 |
| Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group | $6566.2 | $6303.3 |

---

Our discretionary investment portfolio is comprised of short duration bond funds, which typically yield higher than money market rates. Our subsidiaries outside the United States held cash and discretionary investments of $826.1 million at March 31, 2026 and $730.6 million at December 31, 2025. Given the availability of our financial resources and cash expected to be generated through future operations, we do not maintain an available external source of additional liquidity.

Our seed capital investments are redeemable, although we generally expect to be invested for several years for the products to build an investment performance history and until unrelated third-party investors substantially reduce our relative ownership percentage.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The cash and investment presentation on the unaudited consolidated balance sheet is based on the accounting treatment for the cash equivalent or investment item. The following table details how T. Rowe Price Group, Inc.'s interests in cash and investments relate to where they are presented on the unaudited consolidated balance sheet as of March 31, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in millions) | **Cash and cash equivalents** | **Investments** | **Net assets of consolidated investment products**<sup>(1)</sup> | **Total** |
| Cash and discretionary investments | $3729.8 | $459.5 | $— | $4189.3 |
| Redeemable seed capital investments |  | 335.4 | 798.5 | 1133.9 |
| Investments used to hedge the deferred compensation liabilities |  | 1169.8 | 73.2 | 1243.0 |
| Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group | 3729.8 | 1964.7 | 871.7 | 6566.2 |
| Investments in affiliated private investment funds<sup>(2)</sup> |  | 682.1 | 29.1 | 711.2 |
| Investments in affiliated collateralized loan obligations |  | 23.3 |  | 23.3 |
| Investment in UTI and other investments |  | 497.0 |  | 497.0 |
| Total cash and investments attributable to T. Rowe Price Group | 3729.8 | 3167.1 | 900.8 | 7797.7 |
| Redeemable non-controlling interests |  |  | 940.2 | 940.2 |
| As reported on the consolidated balance sheet at March 31, 2026 | $3729.8 | $3167.1 | $1841.0 | $8737.9 |

---

<sup>(1)</sup> *The consolidated T. Rowe Price investment products are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds, ETFs, and funds regulated outside the U.S. The $900.8 million represents the total value at March 31, 2026 of our interest in the consolidated T. Rowe Price investment products. The total net assets of the T. Rowe Price investment products at March 31, 2026 of $1,841.0 million includes assets of $1,954.5 million, less liabilities of $113.5 million as reflected in our unaudited consolidated balance sheets.* 

<sup>(2)</sup> *Includes $157.6 million of non-controlling interests in consolidated entities and represents the portion of these investments, held by related parties, that we cannot sell in order to obtain cash for general operations.*

Our unaudited consolidated balance sheet reflects the cash and cash equivalents, investments, other assets and liabilities of those investment products we consolidate, as well as redeemable non-controlling interests for the portion of these investment products that are held by unrelated third-party investors. Although we can redeem our net interest in these investment products at any time, we cannot directly access or sell the assets held by the products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors. Our interest in these sponsored investment products is generally used as initial seed capital and is recategorized as discretionary when it is determined by management that the seed capital is no longer needed. We assess the discretionary investment products and, when we decide to liquidate our interest, we seek to do so in a way as to not impact the product and, ultimately, the unrelated third-party investors.

**<u>Uses of Liquidity</u>**

Since the end of 2023, we have returned nearly $3.9 billion to stockholders through stock repurchases and regular quarterly dividends, as follows:

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
| (in millions) | **Recurring dividend** | **Stock repurchases** | **Total returned to stockholders** |
| 2024 | $1135.2 | $334.5 | $1469.7 |
| 2025 | 1143.4 | 624.6 | 1768.0 |
| Three months ended March 31, 2026 | 288.4 | 340.4 | 628.8 |
| Total | $2567.0 | $1299.5 | $3866.5 |

---

We anticipate property, equipment, software and other capital expenditures, including internal labor capitalization, for the full-year 2026 to be about $270 million of which nearly all is planned for technology initiatives. We expect to fund our anticipated capital expenditures with operating cash flows and other available resources.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>Cash Flows</u>**

The following table summarizes the cash flows for the three months ended March 31, 2026 and 2025, that are attributable to T. Rowe Price Group, Inc., our consolidated investment products, and the related eliminations required in preparing the statement.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **3/31/2026** | **3/31/2026** | **3/31/2026** | **3/31/2026** | **3/31/2025** | **3/31/2025** | **3/31/2025** | **3/31/2025** |
| (in millions) | **Cash flow attributable to T. Rowe Price Group, Inc.** | **Cash flow attributable to consolidated sponsored investment products** | **Elims** | **As reported** | **Cash flow attributable to T. Rowe Price Group, Inc.** | **Cash flow attributable to consolidated sponsored investment products** | **Elims** | **As reported** |
| Cash flows from operating activities |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $498.2 | $(44.1) | $30.0 | $484.1 | $490.5 | $29.4 | $(14.8) | $505.1 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and impairments of property, equipment and software | 68.8 |  |  | 68.8 | 63.6 |  |  | 63.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization and impairment of acquisition-related assets and retention agreements | 33.9 |  |  | 33.9 | 49.0 |  |  | 49.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value remeasurement of contingent liability |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 49.1 |  |  | 49.1 | 50.3 |  |  | 50.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses recognized on investments | 43.6 |  | (30.0) | 13.6 | (23.1) |  | 14.8 | (8.3) |
| &nbsp;&nbsp;&nbsp;Total non-cash adjustments | 195.4 |  | (30.0) | 165.4 | 139.8 |  | 14.8 | 154.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net redemptions in sponsored investment products used to economically hedge supplemental savings plan liability | 39.2 |  |  | 39.2 | 45.9 |  |  | 45.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in trading securities held by consolidated sponsored investment products |  | (168.9) |  | (168.9) |  | (163.0) |  | (163.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other changes | 233.5 | 73.9 | (2.9) | 304.5 | 95.7 | (3.5) | (1.9) | 90.3 |
| Net cash provided by (used in) operating activities | 966.3 | (139.1) | (2.9) | 824.3 | 771.9 | (137.1) | (1.9) | 632.9 |
| Net cash provided by (used in) investing activities | 18.7 | (0.5) | 41.4 | 59.6 | (95.6) | 3.7 | 44.1 | (47.8) |
| Net cash provided by (used in) financing activities | (633.4) | 169.9 | (38.5) | (502.0) | (489.4) | 120.2 | (42.2) | (411.4) |
| Effect of exchange rate changes on cash and cash equivalents of consolidated sponsored investment products |  | (2.8) |  | (2.8) |  | 0.9 |  | 0.9 |
| Net change in cash and cash equivalents during period | 351.6 | 27.5 |  | 379.1 | 186.9 | (12.3) |  | 174.6 |
| Cash and cash equivalents at beginning of year | 3378.2 | 39.1 |  | 3417.3 | 2649.8 | 63.1 |  | 2712.9 |
| Cash and cash equivalents at end of period | $3729.8 | $66.6 | $— | $3796.4 | $2836.7 | $50.8 | $— | $2887.5 |

---

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*<u>Operating Activities</u>*

Operating activities attributable to T. Rowe Price Group during the first quarter of 2026 provided cash flows of $966.3 million, an increase of $194.4 million from $771.9 million provided during the 2025 period. The increase was primarily driven by a $137.8 million increase in cash flows related to timing differences associated with the cash settlement of our assets and liabilities, a $55.6 million increase in the add-back for non-cash items as detailed in the table above, and a $7.7 million increase in net income. These increases were partially offset by a $6.7 million decrease in proceeds received from net redemptions of investments that economically hedge our supplemental savings plan liability compared to the 2025 period. The remaining change in reported cash flows from operating activities was attributable to the net change in trading securities held in our consolidated investment products' underlying portfolios.

Our interim operating cash flows does not include the cash impact of variable compensation that is accrued throughout the year before being substantially paid out in December.

*<u>Investing Activities</u>*

Net cash provided by investing activities that were attributable to T. Rowe Price Group totaled $18.7 million in 2026 compared with net cash used in investing activities of $95.6 million in 2025. During 2026, we had net proceeds from the sale of investments of $30.9 million compared to $2.1 million during the 2025 period. In 2026, we had net proceeds of $49.8 million in other investing activity compared to net investments of $15.7 million in the 2025 period. The 2026 period includes proceeds from the sale of certain buildings in our real estate portfolio. Additionally, our property and equipment expenditures decreased by $20.0 million compared to the 2025 period primarily due to the completion of our corporate headquarters build out in 2025. We eliminate our capital in those investment products we consolidate in preparing our consolidated statements of cash flows. The remaining change in reported cash flows from investing activities of $4.2 million is primarily related to the net cash removed from our unaudited consolidated balance sheet from consolidating and deconsolidating investment products.

*<u>Financing Activities</u>*

Net cash used in financing activities attributable to T. Rowe Price Group totaled $633.4 million in 2026 compared with $489.4 million in the 2025. In 2026, we used $333.5 million to repurchase 3.7 million shares compared to $217.5 million to repurchase 2.1 million shares in the 2025. Cash flows generated from common stock issued under stock compensation plans decreased by $15.1 million during 2026 compared to 2025. Additionally, the $0.4 million decrease in dividends paid in 2026 was a result of share repurchases over the last year reducing shares outstanding, partially offset by a 2.4% increase in our quarterly dividend per share over prior year. The remaining change in reported cash flows from financing activities was primarily attributable to a $53.4 million increase in net subscriptions from redeemable non-controlling interest holders of our consolidated investment products during 2026.

***<u>CRITICAL ACCOUNTING POLICIES AND ESTIMATES.</u>***

The preparation of financial statements often requires the selection of specific accounting methods and policies from among several acceptable alternatives. Further, significant estimates and judgments may be required in selecting and applying those methods and policies in the recognition of the assets and liabilities in our unaudited consolidated balance sheets, the revenues and expenses in our unaudited consolidated statements of income, and the information that is contained in our significant accounting policies and notes to the unaudited consolidated financial statements. Making these estimates and judgments requires the analysis of information concerning events that may not yet be complete and of facts and circumstances that may change over time. Accordingly, actual amounts or future results can differ materially from those estimates that we include currently in our unaudited consolidated financial statements, significant accounting policies, and notes.

There have been no material changes in the critical accounting policies previously identified in our 2025 Annual Report on Form 10-K.

***<u>NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.</u>***

See *Note 1 - Basis of Preparation and Summary of Significant Accounting Policies* within Item 1. Financial Statements for a discussion of newly issued but not yet adopted accounting guidance.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

***<u>FORWARD-LOOKING INFORMATION.</u>***

From time to time, information or statements provided by or on behalf of T. Rowe Price, including those within this report, may contain certain forward-looking information, including information or anticipated information relating to: our revenues, net income, and earnings per share of common stock; changes in the amount and composition of our assets under management; our expense levels; our effective tax rate; legal or regulatory developments; geopolitical instability; interest rates and currency fluctuations; and our expectations regarding financial markets, future transactions, dividends, stock repurchases, investments, new products and services, capital expenditures, changes in our effective fee rate, and other industry or market conditions. Readers are cautioned that any forward-looking information provided by or on behalf of T. Rowe Price is not a guarantee of future performance. Actual results may differ materially from those in forward-looking information because of various factors including, but not limited to, those discussed below and in Item 1A, Risk Factors, included in our Form 10-K Annual Report for 2025. Further, forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events.

Our future revenues and results of operations will fluctuate primarily due to changes in the total value and composition of assets under our management. Such changes result from many factors, including, among other things: client-related cash inflows and outflows in our products, performance fees, capital allocation-based income, fluctuations in global financial markets that result in appreciation or depreciation of the assets under our management, our introduction of new investment products, and changes in retirement savings trends relative to participant-directed investments and defined contribution plans.

Our ability to attract and retain investors' assets under our management is dependent on investor sentiment and confidence; the relative investment performance of the T. Rowe Price mutual funds and other managed investment products compared to competing offerings and market indexes; the ability to maintain our investment management and administrative fees at appropriate levels; the impact of changes in interest rates and inflation; competitive conditions in the mutual fund, asset management, and broader financial services sectors; our level of success in implementing our strategy to expand our business; and our ability to attract and retain key personnel. Our revenues are substantially dependent on fees earned under contracts with the T. Rowe Price funds and could be adversely affected if the independent directors of one or more of the T. Rowe Price funds terminated or significantly altered the terms of the investment management or related administrative services agreements. Non-operating investment income will also fluctuate primarily due to the size of our investments, changes in their market valuations, and any other-than-temporary impairments that may arise or, in the case of our equity method investments, our proportionate share of the investees' net income.

Our future results are also dependent upon the level of our expenses, which are subject to fluctuation for the following or other reasons: changes in the level of our advertising and promotion expenses in response to market conditions, including our efforts to expand our investment advisory business to investors outside the U.S. and to further penetrate our distribution channels within the U.S.; the pace and level of spending to support key strategic priorities; variations in the level of total compensation expense due to, among other things, bonuses, restricted stock units and other equity grants, other incentive awards, our supplemental savings plan, changes in our employee count and mix, and competitive factors; any goodwill, intangible asset or other asset impairment that may arise; fluctuation in foreign currency exchange rates applicable to the costs of our international operations; expenses and capital costs, such as technology assets, depreciation, amortization, and research and development, incurred to maintain and enhance our administrative and operating services infrastructure; the timing of the assumption of all third party research payments, unanticipated costs that may be incurred to protect investor accounts and the goodwill of our clients; and disruptions of services, including those provided by third parties, such as fund and products recordkeeping, facilities, communications, power, and the mutual fund transfer agent and accounting systems, as a result of extreme events, cyberattacks or otherwise.

Our business is also subject to substantial governmental regulation, and changes in legal, regulatory, accounting, tax, and compliance requirements may have a substantial effect on our operations and results, including, but not limited to, effects on costs that we incur and effects on investor interest in investment products and investing in general or in particular classes of mutual funds or other investments.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

There has been no material change in our market risks from those provided in Item 7A of the Form 10-K Annual Report for 2025.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Item 4. Controls and Procedures.**

Our management, including our principal executive and principal financial officers, have evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2026. Based on that evaluation, our principal executive and principal financial officers have concluded that our disclosure controls and procedures as of March 31, 2026, are effective at the reasonable assurance level to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, including this Form 10-Q quarterly report, is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms, and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our principal executive and principal financial officers, have evaluated any change in our internal control over financial reporting that occurred during the first quarter of 2026, and has concluded that there was no change during the first quarter of 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings.**

For information about our legal proceedings, please see our Commitments and Contingencies footnote to our unaudited consolidated financial statements in Part 1 of this Form 10-Q.

**Item 1A. Risk Factors.**

There have been no material changes in the information provided in Item 1A of our Form 10-K Annual Report for 2025.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.** 

(c) Repurchase activity during the first quarter of 2026 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Month** | **Total Number of<br>Shares Purchased** | **Average Price<br>Paid per Share\*** | **Total Number of<br>Shares Purchased as<br>Part of Publicly<br>Announced Program** | **Maximum Number of Shares that May Yet Be Purchased Under the Program** |
| January 1 - January 31 | 156696 | $104.39 | 156696 | 12045150 |
| February 1 - February 28 | 1107510 | $94.51 | 1107510 | 10937640 |
| March 1 - March 31 | 2430019 | $89.22 | 2430019 | 8507621 |
| Total | 3694225 | $91.45 | 3694225 |  |

---

<sup>\*Amounts presented exclude estimated excise tax</sup>

Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorization, outstanding shares surrendered to us to pay the exercise price in connection with swap exercises of stock options, and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards. Of the total number of shares purchased during the first quarter of 2026, all were part of a publicly announced program.

The following table details the changes in and status of the Board of Directors' outstanding publicly announced board authorization.

---

| | | | |
|:---|:---|:---|:---|
| **Authorization Dates** | **Maximum Number of Shares that May Yet Be Purchased at 1/1/2026** | **Total Number of<br>Shares Purchased** | **Maximum Number of Shares that May Yet Be Purchased at 3/31/2026** |
| December 2024 | 12201846 | (3694225) | 8507621 |

---

**Item 3. Defaults Upon Senior Securities.**

Not applicable.

**Item 4. Mine Safety Disclosures.** 

Not applicable.

**Item 5. Other Information.**

Not applicable.

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Item 6. Exhibits.**

The following exhibits required by Item 601 of Regulation S-K are filed herewith, except for Exhibit 32 that is furnished herewith.

---

| | |
|:---|:---|
| 3(i) | [Charter of T. Rowe Price Group, Inc., as reflected by Articles of Restatement dated June 20, 2018. (Incorporated by reference from Form 10-Q Quarterly Report filed on July 25, 2018.)](https://www.sec.gov/Archives/edgar/data/1113169/000111316918000018/articlesofrestatementfin.htm) |
| 3(ii) | [Amended and Restated By-Laws of T. Rowe Price Group, Inc. as of February 9, 2021. (Incorporated by reference from Form 10-K Annual Report filed on February 11, 2021.)](https://www.sec.gov/Archives/edgar/data/1113169/000111316921000006/exhibit3-1trpgamendedandre.htm) |
| 15 | [Report from KPMG LLP, independent registered public accounting firm, re unaudited interim financial information.](trow-ex15_q12026.htm) |
| 31(i).1 | [Rule 13a-14(a) Certification of Principal Executive Officer.](trow-ex31i1_q12026.htm) |
| 31(i).2 | [Rule 13a-14(a) Certification of Principal Financial Officer.](trow-ex31i2_q12026.htm) |
| 32 | [Section 1350 Certifications.](trow-ex32_q12026.htm) |
| 101 | The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group's unaudited consolidated interim financial statements and notes that are included in this Form 10-Q Report. |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document |
| 101.LAB | XBRL Taxonomy Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document |
| 101.DEF | XBRL Taxonomy Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

**20**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on April 30, 2026.

T. Rowe Price Group, Inc.

By: /s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

**20**

## Ex-15

EXHIBIT 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Letter from KPMG LLP, independent registered public accounting firm, re unaudited interim financial information

April 30, 2026

T. Rowe Price Group, Inc.

Baltimore, Maryland

Re: Registration Statements No. 033-7012, No. 333-59714, No. 333-120882, No. 333-120883, No. 333-142092, No. 333-167317, No. 333-180904, No. 333-199560, No. 333-212705 , No. 333-217483, No. 333-238319, and No. 333-273601.

With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated April 30, 2026 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

Baltimore, Maryland

## Ex-31

EXHIBIT 31(i).1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rule 13a-14(a) Certification of Principal Executive Officer

I, Robert W. Sharps, certify that:

1. I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended March 31, 2026 of T. Rowe Price Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

April 30, 2026

/s/ Robert W. Sharps

Chief Executive Officer and President

## Ex-31

EXHIBIT 31(i).2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rule 13a-14(a) Certification of Principal Financial Officer

I, Jennifer B. Dardis, certify that:

1. I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended March 31, 2026 of T. Rowe Price Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

April 30, 2026

/s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

## Ex-32

EXHIBIT 32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Section 1350 Certifications&nbsp;&nbsp;&nbsp;&nbsp;

We certify, to the best of our knowledge, based upon a review of the Form 10-Q Quarterly Report for the quarterly period ended March 31, 2026, of T. Rowe Price Group, Inc., that:

(1) The Form 10-Q Quarterly Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of T. Rowe Price Group, Inc.

April 30, 2026

/s/ Robert W. Sharps

Chief Executive Officer and President

/s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

<br>